Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT02932007 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Chloroquine for Patients With Symptomatic Persistent Atrial Fibrillation: A Prospective Pilot Study

StatusRecruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated August 19, 2019 (before its estimated March 2020 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion date: Mar 2019 to Mar 2020
    • Study completion date: Sep 2019 to Sep 2020
    v8
  2. Eligibility criteria shortened, about 10 words
    • Site contact updated
    • Study description shortened, about 3 words
    • Study title expanded, about 4 words
    v7
  3. Site contact updatedv6
  4. Primary completion date: Dec 2017 to Mar 2019
    • Start date: Jan 2017 to Mar 28, 2017
    • Study completion date: Dec 2018 to Sep 2019
    • Site contact updated
    v5
  5. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 1
    • Start date: Dec 2016 to Jan 2017
    v4
Show 2 earlier versionsHide 2 earlier versions
  1. Re-verified, no change to tracked fieldsv3
  2. Secondary endpoints: 4 to 6v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this pilot study is to explore the efficacy of chloroquine in terminating persistent AF and assess its potential role as a pharmacological cardioversion agent for the management of AF.
Trial Details
NCT Number NCT02932007
Lead Sponsor University of South Florida
Conditions
(from sponsor)		 Atrial Fibrillation
Related terms Atrial Fibrillation
Enrollment 40 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov